A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.

Part of paid clinical trials in Peoria, Arizona.

Sponsor
Paradigm Biopharmaceuticals Ltd.
Study ID
NCT06917404
Phase
PHASE3
Status
Recruiting

Conditions

  • Osteoarthritis, Knee

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Pentosan Polysulfate Sodium twice weekly — DRUG
    Subcutaneous injection, 2 mg/kg twice weekly for 6 weeks
  • Placebo — DRUG
    Placebo, subcutaneous injection, twice weekly for 6 weeks

Study Details

The purpose of this study is to measure the change in pain and function with subcutaneous injections of pentosan polysulfate sodium (PPS) compared with subcutaneous injections of placebo in participants with knee OA pain. Study details include: * The study duration will be up to 64 weeks. * The treatment duration will be 6 weeks. * The visit frequency will be twice weekly during treatment. * The visit/contact frequency will be every 4-6 weeks during the 52-week Follow-up period. * Approximately 466 participants will be enrolled into this study.

Key Dates

Start date
May 29, 2025
Status verified
Nov 2025
Primary completion
Jul 31, 2027
Completion
Jul 31, 2027

Study Design

Enrollment
466 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: PPS
    Pentosan polysulfate sodium 2mg/kg twice weekly for 6 weeks
  • Placebo Comparator: Placebo
    Placebo (Sodium Chloride Injection, 0.9%) twice weekly for 6 weeks

Primary Outcome Measure

Change from baseline at Day 112 in knee pain as assessed by the weekly average of daily pain (ADP) score on the numerical rating scale (NRS) 11-point (0-10) scale. [ Time Frame: Baseline, Daily to Day 112 ]

Central Contacts

Locations (40)

FacilityCityStateZIPSite coordinators
Onyx Clinical Research-PeoriaPeoriaArizona85381
Study Coordinator
602-830-3794
Shweta Mehta, MD (PRINCIPAL_INVESTIGATOR)
Del Sol Research Management, LLCTucsonArizona85715
Study Coordinator
520-257-3881
Vicki Kalen, MD (PRINCIPAL_INVESTIGATOR)
Orange County Research InstituteAnaheimCalifornia92801
Study Coordinator
714-635-7100
Steve Sitar, MD (PRINCIPAL_INVESTIGATOR)
Core Healthcare GroupCerritosCalifornia90703
Study Coordinator
562-287-8906
Francisco Badar, MD (PRINCIPAL_INVESTIGATOR)
Triwest Research CenterChula VistaCalifornia91910
Study Coordinator
619-334-4735
Arthur Mabaquiao, MD (PRINCIPAL_INVESTIGATOR)
Seaside Medical GroupOceansideCalifornia92058
Study Coordinator
760-826-2020
Paul Lizotte, MD (PRINCIPAL_INVESTIGATOR)
Paragon RX ClinicalSanta AnaCalifornia92703
Study Coordinator
714-880-4448
Kelvin Mai, MD (PRINCIPAL_INVESTIGATOR)
Encompass Clinical ResearchSpring ValleyCalifornia91978
Study Coordinator
619-871-8687
Hanid Audish, MD (PRINCIPAL_INVESTIGATOR)
Focus Clinical ResearchWest HillsCalifornia91307
Study Coordinator
813-253-8966
Hessam Aazami, MD (PRINCIPAL_INVESTIGATOR)
Clinical Research of West Florida - ClearwaterClearwaterFlorida33765
Study Coordinator
727-466-0078
Robert Levin, MD (PRINCIPAL_INVESTIGATOR)
GNP ResearchCooper CityFlorida33024
Study Coordinator
754-248-3589
Mark Jaffe, MD (PRINCIPAL_INVESTIGATOR)
Arrow Clinical TrialsDaytona BeachFlorida32117
Study Coordinator
386-278-8000
David Billmeier, MD (PRINCIPAL_INVESTIGATOR)
AGA Clinical TrialsHialeahFlorida33012
Study Coordinator
305-819-1551
Dario Altamirano, MD (PRINCIPAL_INVESTIGATOR)
Evolution Clinical TrialsMiamiFlorida33122
Study Coordinator
786-706-1216
Gilberto Perez, MD (PRINCIPAL_INVESTIGATOR)
Well Pharma Medical ResearchMiamiFlorida33173
Study Coordinator
305-665-4818
Eddie Armas, MD (PRINCIPAL_INVESTIGATOR)
K2 Medical ResearchOrlandoFlorida32806
Study Coordinator
407-987-3284
Beatriz Colon, MD (PRINCIPAL_INVESTIGATOR)
Progressive Medical ResearchPort OrangeFlorida32127
Study Coordinator
386-295-9363
Richard Mohammed, MD (PRINCIPAL_INVESTIGATOR)
Phoenix Clinical ResearchTamaracFlorida33321
Study Coordinator
561-715-8188
Richard Berkowitz, MD (PRINCIPAL_INVESTIGATOR)
Conquest ResearchWinter ParkFlorida32789
Study Coordinator
689-488-9124
Anand Patel, MD (PRINCIPAL_INVESTIGATOR)
Chicago Clinical Research, IncChicagoIllinois60607
Study Coordinator
312-791-3241
Dennis Levinson, MD (PRINCIPAL_INVESTIGATOR)
Northwestern UniversityChicagoIllinois60611
Study Coordinator
312-503-2315
Thomas Schnitzer, MD (PRINCIPAL_INVESTIGATOR)
Sinai Hospital of BaltimoreBaltimoreMaryland21215
Study Coordinator
410-601-9467
James Nace, MD (PRINCIPAL_INVESTIGATOR)
Profound ResearchFarmington HillsMichigan48334
Study Coordinator
947-254-1920
Barry Feldman, MD (PRINCIPAL_INVESTIGATOR)
Insight Research InstituteFlintMichigan48507
Study Coordinator
(810) 275-1964
Vincent Rampersaud, MD (PRINCIPAL_INVESTIGATOR)
Rochester Medical GroupRochester HillsMichigan48307
Study Coordinator
248-844-6000
Michael Margolis, MD (PRINCIPAL_INVESTIGATOR)
Onyx Clinical Research - Rochester HillsTroyMichigan48085
Study Coordinator
682-433-9813
Ramkrishna Surendran, MD (PRINCIPAL_INVESTIGATOR)
Physician Research CollaborationLincolnNebraska68516
Study Coordinator
402-420-1212
Melvin Churchill, MD (PRINCIPAL_INVESTIGATOR)
Alpine Healthcare Family PracticeLas VegasNevada89109
Study Coordinator
702-290-2951
Robert Kaplan, MD (PRINCIPAL_INVESTIGATOR)
Drug Trials AmericaHartsdaleNew York10530
Study Coordinator
914-341-2346
Michael Gerdis, MD (PRINCIPAL_INVESTIGATOR)
Groth Pain & Spine - Long Island, NYMineolaNew York11501
Study Cooordinator
516-816-8160
Mariyam Wasay, MD (PRINCIPAL_INVESTIGATOR)
IMA Clinical Research ManhattanNew YorkNew York10036
Study Coordinator
914-966-6986
James Greenwald, MD (PRINCIPAL_INVESTIGATOR)
Groth Pain and Spine ManagementSmithtownNew York11787
Study Coordinator
516-816-8160
Christopher Amen, MD (PRINCIPAL_INVESTIGATOR)
FutureSearch Trials of NeurologyAustinTexas78731
Study Coordinator
512-380-9595
Gregory Tempest, MD (PRINCIPAL_INVESTIGATOR)
FutureSearch Trials of DallasDallasTexas75251
Study Coordinator
214-369-2600
Michael Downing, MD (PRINCIPAL_INVESTIGATOR)
Clinical Trial NetworkHoustonTexas77074
Study Coordinator
713-484-6947
Alan Reichman, MD (PRINCIPAL_INVESTIGATOR)
DM Clinical ResearchHoustonTexas77065
Study Coordinator
346-550-9559
Tiffany Huynh, MD (PRINCIPAL_INVESTIGATOR)
Vilo Research GroupHoustonTexas77017
Study Coordinator
832-660-5095
Luis Zepeda, MD (PRINCIPAL_INVESTIGATOR)
Epic Clinical ResearchLewisvilleTexas75057
Study Coordinator
469-361-8007
Manjoo Sharma, MD (PRINCIPAL_INVESTIGATOR)
Quality Research Inc.San AntonioTexas78209
Study Coordinator
210-824-5678
Robert Morin, MD (PRINCIPAL_INVESTIGATOR)
Rio Clinical TrialsOgdenUtah84404
Study Coordinator
801-876-5785
Stephen Bruce, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Peoria, AZ

Related Studies